Patients with severe or critical COVID-19 usually display features of systemic inflammation, with increased levels of proinflammatory cytokines (interleukin (IL)-1 or IL-6) and other acute phase reactants (C-reactive protein (CRP), D-dimer or ferritin [3]). This evidence concerns the gene CRP and COVID-19.